Nancy Yu

Nancy Yu is a visionary individual dedicated to bridging the gap between science and reality. Her passion lies in unraveling the complexities of science and aligning diverse communities to achieve common goals.

With a background in genetics research at Penn, Nancy understands the interconnectedness of science, business, and patient care, a theme that has resonated throughout her career.

Prior to her role as the co-founder and CEO of AllStripes, Nancy made significant contributions at 23andMe, where she harnessed the power of collaboration to advance drug discovery and development.

Her experience as a biotech investment banker and healthcare investor on Wall Street provided her with a profound insight into the financial and business aspects of healthcare innovations.

Nancy's educational journey includes studies in Finance and Economics at The Wharton School, complemented by a strong foundation in Molecular Biology from the University of Pennsylvania.

She is a former member of YPO - Barbary Coast and has held key positions at reputable organizations such as 23andMe, H.I.G. Capital, and Jefferies.

Nancy's driving force is to be surrounded by individuals who share her fervor for driving impactful change, particularly within the rare disease community.

In her personal life, Nancy strives to tackle challenges with humility, always seeking to be inspired by new horizons.